Home » Topics » Regulatory » Patents

Patents
RSS

Antibodies targeting glycosylated CD44 synthesized at Go Therapeutics

Oct. 1, 2021

PTGER4 antagonists discovered at Hubei Bio-Pharmaceutical, Humanwell Healthcare

Oct. 1, 2021

Leiden University and collaborators patent monoglyceride lipase inhibitors

Oct. 1, 2021

New antivirals presented by EcoSynth, Transmare Chemie

Oct. 1, 2021

Aston University descibres new antibacterials

Oct. 1, 2021

New CDK12 inhibitors presented by Bayer, Deutsches Krebsforschungszentrum

Sep. 30, 2021

Ennovabio, Shanghai Ennova Biopharmaceutical patent MAP4K1 inhibitors

Sep. 30, 2021

Sironax describes new ferroptosis inhibitors

Sep. 30, 2021

Medshine Discovery identifies new S1PR1 agonists

Sep. 30, 2021

New KDM1A inhibitors discovered at Shenyang Pharmaceutical University

Sep. 29, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...